Clinical and electrophysiological features of seven patients with moving toes syndrome: Is it a type of spinal segmental myoclonus?
Objective: We aimed to present a case series of moving toes syndrome to show how clinical presentation and electrophysiological findings may change. Background: The moving…Management of fragility fractures in Parkinson’s Disease (PD)
Objective: To assess the management of osteoporotic fragility fractures in patients with PD attending a Movement disorders clinic. Background: Patients with PD have a high…End of Life Care in Parkinson’s Disease
Objective: We aim to identify the current practice at the Royal Devon & Exeter NHS trust of managing Patients with PD at the end of…Stiff-limb syndrome with cerebellar features and atypical EMG findings responds to IVIG
Objective: To describe a case of Stiff-Limb Syndrome with ataxic features which had delayed EMG findings and improvement to IVIG. Background: Stiff-Person Syndrome (SPS) is…Efficacy of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson’s disease: results from the Phase 3 study dose-titration phase
Objective: To determine the dose of APL-130277 required by each patient with Parkinson’s Disease (PD) to turn from OFF to Full ON. This dose is…Transcranial direct current stimulation enhances consolidation of learning in Parkinson’s disease
Objective: To examine the effects of training combined with transcranial direct current stimulation (tDCS) on writing performance and consolidation of learning in Parkinson’s disease (PD).…Study in Parkinson’s Disease of Exercise (SPARX): A Randomized, Controlled Futility Trial
Objective: Our first objective was to determine whether people with de novo Parkinson’s disease (PD) are able to exercise at either 60-65% maximal heart rate…Using an Objective Measure of Movement to Quantify Night Time Sleep
Objective: To assess whether data obtained from the Parkinson’s KinetiGraph (PKG), an objective movement recording system for Parkinson’s disease (PD), could be used to provide…Drug utilization characteristics in individuals with early Parkinson’s disease interim analysis of the STEADY-PD III study
Objective: To review symptomatic therapy (ST) utilization trends in individuals with early Parkinson’s disease (PD). Background: There are changing trends in ST utilization in early…Disease-modifying effect of Zonisamide with the induction of BDNF and TrkB expression
Objective: To evaluate to predictors of the disease-modifying effect of drugs on Parkinson’s disease (DM-PD) according to long-term therapeutic investigation, especially regarding the non-dopaminergic agent…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 155
- Next Page »